Clinical Trial Update: Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial update on allogeneic stem cell transplantation for multiple myeloma and myelofibrosis; the study status is terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Myelofibrosis

Drugs mentioned

• Allogeneic stem cell transplantation

Snippet

Sponsor: University of Utah | Conditions: Anemia, ASXL1 Gene Mutation | Phase 2 | Status: TERMINATED | Results posted: 2020-05-27